The study also examined two cases of postmortem human spinal cord with progressive MS, finding that TNFR2 was localized to activated microglia/macrophages and reactive astrocytes within white matter lesions, but it was not localized to neurons or mature oligodendrocytes. This evidence concerns the gene TNFRSF1B and myeloid sarcoma.